title: Treatment of ankylosing spondylitis with infliximab.
authors.forename: C A
authors.initials: CA
authors.lastname: Boeger
authors.forename: H
authors.initials: H
authors.lastname: Wittwer
authors.forename: M
authors.initials: M
authors.lastname: Schattenkirchner
authors.forename: H
authors.initials: H
authors.lastname: Kellner
authors.forename: W
authors.initials: W
authors.lastname: Kellner
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D008297:Male; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab